Altaras M - Search Results

1

Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.

Ramus SJ, Bobrow LG, Pharoah PD, Finnigan DS, Fishman A, Altaras M, Harrington PA, Gayther SA, Ponder BA, Friedman LS. Ramus SJ, et al. Among authors: altaras m. Genes Chromosomes Cancer. 1999 Jun;25(2):91-6. doi: 10.1002/(sici)1098-2264(199906)25:2<91::aid-gcc3>3.0.co;2-5. Genes Chromosomes Cancer. 1999. PMID: 10337991

2

Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations.

Ramus SJ, Fishman A, Pharoah PD, Yarkoni S, Altaras M, Ponder BA. Ramus SJ, et al. Among authors: altaras m. Eur J Surg Oncol. 2001 Apr;27(3):278-81. doi: 10.1053/ejso.2000.1097. Eur J Surg Oncol. 2001. PMID: 11373105

3

High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.

Biron-Shental T, Drucker L, Altaras M, Bernheim J, Fishman A. Biron-Shental T, et al. Among authors: altaras m. Eur J Surg Oncol. 2006 Dec;32(10):1097-100. doi: 10.1016/j.ejso.2006.03.032. Epub 2006 May 2. Eur J Surg Oncol. 2006. PMID: 16650962

4

Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer.

Bruchim I, Altaras M, Fishman A. Bruchim I, et al. Among authors: altaras m. Gynecol Oncol. 2002 Sep;86(3):274-8. doi: 10.1006/gyno.2002.6759. Gynecol Oncol. 2002. PMID: 12217748

5

Successful carboplatin desensitization in patients with proven carboplatin allergy.

Confino-Cohen R, Fishman A, Altaras M, Goldberg A. Confino-Cohen R, et al. Among authors: altaras m. Cancer. 2005 Aug 1;104(3):640-3. doi: 10.1002/cncr.21168. Cancer. 2005. PMID: 15977213 Free article.

6

Subfertility, use of fertility treatments and BRCA mutation status and the risk of ovarian cancer.

Lerner-Geva L, Chetrit A, Farhi A, Lubin F, Sadezki S; National Israel Ovarian Cancer Study Group. Lerner-Geva L, et al. Arch Gynecol Obstet. 2022 Jul;306(1):209-217. doi: 10.1007/s00404-021-06355-6. Epub 2022 Jan 18. Arch Gynecol Obstet. 2022. PMID: 35039881

7

A second primary malignancy in a cohort of patients with epithelial ovarian cancer--characteristics of diagnosis.

Fishman A, Aviram R, Beyth Y, Bernheim J, Altaras M. Fishman A, et al. Among authors: altaras m. Eur J Gynaecol Oncol. 1998;19(3):280-3. Eur J Gynaecol Oncol. 1998. PMID: 9641231

8

Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridization.

Fishman A, Shalom-Paz E, Fejgin M, Gaber E, Altaras M, Amiel A. Fishman A, et al. Among authors: altaras m. Int J Gynecol Cancer. 2005 Mar-Apr;15(2):261-6. doi: 10.1111/j.1525-1438.2005.15213.x. Int J Gynecol Cancer. 2005. PMID: 15823109 Free article.

9

A modified, prolonged desensitization protocol in carboplatin allergy.

Goldberg A, Confino-Cohen R, Fishman A, Beyth Y, Altaras M. Goldberg A, et al. Among authors: altaras m. J Allergy Clin Immunol. 1996 Oct;98(4):841-3. doi: 10.1016/s0091-6749(96)70134-3. J Allergy Clin Immunol. 1996. PMID: 8876561 No abstract available.

10

Inflammatory skin metastases from ovarian carcinoma--a case report and review of the literature.

Schonmann R, Altaras M, Biron T, Bernheim J, Fishman A. Schonmann R, et al. Among authors: altaras m. Gynecol Oncol. 2003 Sep;90(3):670-2. doi: 10.1016/s0090-8258(03)00366-4. Gynecol Oncol. 2003. PMID: 13678744 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page